# Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy

> **NCT07291700** · — · RECRUITING · sponsor: **Bayer** · enrollment: 167 (estimated)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Hydrotalcite (Talcid, BAYX002833)

## Key facts

- **NCT ID:** NCT07291700
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-18
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 167 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07291700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07291700, "Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT07291700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*